共 50 条
- [41] Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme JOURNAL OF CROHNS & COLITIS, 2024, 18 (05): : 695 - 707
- [42] Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age Advances in Therapy, 2017, 34 : 542 - 559
- [43] Ozanimod Efficacy and Safety in Older Patients With Ulcerative Colitis: A Post Hoc Analysis From True North AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S25 - S25
- [45] Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial LANCET, 2021, 397 (10292): : 2372 - 2384
- [46] Efficacy of ozanimod in vedolizumab-exposed patients with ulcerative colitis: a phase 3 True North post hoc analysis JOURNAL OF CROHNS & COLITIS, 2023, 17 : 507 - 508
- [47] Efficacy of Ozanimod in Vedolizumab-Exposed Patients With Ulcerative Colitis: A Phase 3 True North Post Hoc Analysis AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S593 - S594